NASDAQ · RPID

Rapid Micro Biosystems, Inc.

$2.01 +$0.02 (+1.01%) 1D Market open
Session Pulse Regular session 2 mentions on Fri No new SEC filings since Mon close its sector ranked 9/11 this week Full pulse →

Key Metrics

$99.15M
Market cap
P/E · TTM
$34.38M
Revenue · TTM
−$50.14M
Net income
EPS · TTM $-1.14
Dividend yield
Free cash flow −$37.98M
Beta · 1Y 2.01
EBITDA · TTM −$46.16M
Gross margin 1.1%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 24
    2 insider transaction filings hit the record.

    Form 4s are events, not verdicts — officers, directors, and 10% owners reporting their own trades. The forms post hours before the media writes them up.

    RECEIPT: SEC FORM 4 × 2, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 10
    The stock moved +17.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 10
  • Jun 16
    From its Feb 26 high, the share price fell 63%.

    Peak close $4.47 on Feb 26; trough close $1.66 on Jun 16. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -63%
  • Mar 12
    The stock moved -21.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$99.15M
Enterprise value$95.25M
Shares outstanding49.8M
52-wk range$1.66 – $4.94
Avg volume · 20D147.5K
Net cash $3.90M
Book value / share$0.46
IndustryLaboratory Analytical Instruments
ExchangeNASDAQ
About Rapid Micro Biosystems, Inc.
IPO dateJul 15, 2021
Employees171

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.88
P/FCF
EV/EBITDA
EV/Sales2.77
Graham №

Profitability

Gross 1.1%
Operating -143.3%
Net -145.8%
FCF -110.5%
ROE / ROIC -104.7% · —

Financial Health

Current ratio2.57
Quick ratio1.66
Debt / equity0.93
Debt / EBITDA -0.41
Net cash $3.90M
Working capital$30.11M

Cash Flow · TTM

Operating CF −$37.06M
Capex −$925.00K
Free cash flow −$37.98M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

-12.1
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings